Presentation slide: RE-DUAL PCI –antithrombotic therapy in AF patients who have undergone stent PCI | boehringerone.com
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial - The Lancet
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet
Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic ...
TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention | USC Journal
The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status | tctmd.com
on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt download
Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a “less is more” concept regimen - Journal of Cardiology
on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt download
The Challenge of AF and PCI: Practical Strategies to Improve Outcomes - ppt download
Superior safety of dual therapy with dabigatran and clopidogrel vs. triple therapy with warfarin, aspirin and clopidogrel in the RE-DUAL PCI trial: What is key, the strategy or the drug? - European
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation | NEJM
Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - Journal of Cardiology
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation | NEJM
Triple Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. Mar…
Contemporary Revascularization Dilemmas in Older Adults | Journal of the American Heart Association
Ticagrelor With or Without Aspirin After Complex PCI | Journal of the American College of Cardiology
Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI
Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - Journal of Cardiology
on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt download
Triple Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. Mar…
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy - Canadian Journal of Cardiology
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel
Atrial Fibrillation and PCI - ppt download
Comparison of Dabigatran Plus a P2Y12 Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI - The American Journal of Medicine
